Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
US7309800B2 · kind B2 · utility
11Cited by
47References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2006 |
| Grant date | Dec 18, 2007 |
| Priority date | — |
| Expiry date | Nov 3, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.